Farther Finance Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$180K Buy
1,200
+947
+374% +$103K ﹤0.01% 2320
2026
Q1
$23.1K Buy
253
+88
+53% +$8.84K ﹤0.01% 3554
2025
Q4
$16.9K Sell
165
-2
-1% -$179 ﹤0.01% 3550
2025
Q3
$10.4K Buy
167
+100
+149% +$5.44K ﹤0.01% 3426
2025
Q2
$3.49K Buy
67
+34
+103% +$1.52K ﹤0.01% 3508
2025
Q1
$1.4K Sell
33
-20
-38% -$863 ﹤0.01% 3514
2024
Q4
$1.62K Sell
53
-921
-95% -$25.9K ﹤0.01% 3084
2024
Q3
$22.3K Buy
974
+938
+2,606% +$26.5K ﹤0.01% 2042
2024
Q2
$1.02K Buy
+36
New +$838 ﹤0.01% 3075
2024
Q1
Sell
-183
Closed -$4.95K 3644
2023
Q4
$4.95K Buy
183
+181
+9,050% +$4.75K ﹤0.01% 1970
2023
Q3
$59 Sell
2
-10
-83% -$352 ﹤0.01% 2566
2023
Q2
$430 Hold
12
﹤0.01% 2192
2023
Q1
$281 Buy
12
+2
+20% +$57 ﹤0.01% 2136
2022
Q4
$272 Buy
+10
New +$458 ﹤0.01% 1967

Other funds holding GH

Farther Finance Advisors's GH Position: Q2 2026 in Review

Farther Finance Advisors increased its Guardant Health (GH) stake by 374% in Q2 2026, buying an estimated $103K and bringing the position to 1,200 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #2320.

Farther Finance Advisors first reported a position in GH in Q4 2022 and has held it in 14 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Farther Finance Advisors held 1,200 shares of Guardant Health worth $180K as of Q2 2026.
  • Farther Finance Advisors bought 947 Guardant Health shares in Q2 2026, an estimated $103K.
  • Guardant Health made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2320 holding.
  • Farther Finance Advisors first reported a position in Guardant Health in Q4 2022 and has held it in 14 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.